Tinea pedis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female aged 18 to 65 years old; 2. Able and willing to provide signed informed consent; 3. Patients with interdigital, or parts of palmoplantar blisters, dipping, or chapped, keratosis, squamous skin rash; 4. Dander microscopic fungi and / or culture-positive
Exclusion criteria
Exclusion criteria: 1. Patients in past 3 months had received systemic antifungal agents or local antifungal treatment in the past two weeks. 2. Received long-term corticosteroids or immunosuppressant. 3. Women who are lactating and pregnant. 4. Patients received radiation therapy, anti-virus, anti-bacterial, or anti-worm treatment within the past two weeks. 5. Patients with onychomycosis or other bacterial infection erysipelas. 6. Patients with cardiovascular, liver, kidney, brain and hematopoietic diseases; suffering from mental illness, cancer, and autoimmune diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure and not cure rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence (including relapse or reinfection) rate;The quality of life;Clinical evaluation of clinical symptoms;Parameters of mycology; | — |
Countries
China